Brief: Oncosec Announces Publication In Clinical Cancer Research Of Data Supporting The Therapeutic Potential Of Lead Product Candidate, Tavo™, In Triple Negative Breast Cancer
01/03/2021 14:11
March 1 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC ANNOUNCES PUBLICATION IN CLINICAL CANCER RESEARCH
OF
DATA SUPPORTING THE THERAPEUTIC POTENTIAL OF LEAD PRODUCT
CANDIDATE, TAVO™, IN TRIPLE NEGATIVE BREAST CANCER
Source text for Eikon: ID:nPn89xT5ca
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq